References
1Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). Accessed at: https://www.who.int/publications-detail/report-of-the-who-china-joint-mission-on-coronavirus-disease-2019-(covid-19) on March 20, 2020.
2Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical Characteristics Of Coronavirus Disease 2019 In China. N Engl J Med 2020;28.
3Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020;395:1054-62.
4Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020:24.
5Dhital R, Pandey RK, Poudel DR, Oladunjoye O, Paudel P, Karmacharya P. All-cause hospitalizations and mortality in systemic lupus erythe- matosus in the US: Results from a national inpatient database. Rheumatol Int 2020;40:393-7.
6Ogdie A, Maliha S, Shin D, Love TJ, Baker J, Jiang Y, et al. Cause-specific mortality in patients with psoriatic arthritis and rheumatoid arthritis, Rheumatology 2017;56:907-11.
7D’Antiga L. Coronaviruses and immuno- suppressed patients. The facts during the third epidemic. Liver Transpl. 2020 March 20.
8T.C Sağlık Bakanlığı COVID-19 Rehberi. Accessed at: https://covid19bilgi.saglik.gov.tr/depo/rehberler/COVID-19_Rehberi.pdf on April 16,2020
9Gianfrancesco M, Hyrich KL, Gossec L, Strangfeld A, Carmona L, Mateus EF, et al. Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries. Lancet Rheumatology. 2020 April 16.
